Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tomography, Optical Coherence | 46 | 2022 | 2907 | 7.250 |
Why?
|
Fluorescein Angiography | 30 | 2022 | 1051 | 6.190 |
Why?
|
Retinal Vessels | 18 | 2022 | 851 | 4.800 |
Why?
|
Choroid | 8 | 2022 | 352 | 3.300 |
Why?
|
Retinal Diseases | 9 | 2021 | 704 | 2.590 |
Why?
|
Diabetic Retinopathy | 7 | 2021 | 1275 | 2.490 |
Why?
|
Visual Acuity | 21 | 2022 | 2662 | 1.920 |
Why?
|
Retinal Telangiectasis | 3 | 2019 | 25 | 1.820 |
Why?
|
Optic Disk | 7 | 2020 | 421 | 1.780 |
Why?
|
Macular Degeneration | 12 | 2021 | 1005 | 1.740 |
Why?
|
Vitrectomy | 4 | 2021 | 391 | 1.550 |
Why?
|
Choroid Diseases | 4 | 2022 | 63 | 1.530 |
Why?
|
Retinal Artery | 4 | 2021 | 109 | 1.530 |
Why?
|
Retinal Vein Occlusion | 4 | 2021 | 149 | 1.490 |
Why?
|
Ciliary Arteries | 3 | 2019 | 19 | 1.390 |
Why?
|
Wet Macular Degeneration | 5 | 2019 | 162 | 1.370 |
Why?
|
Retina | 9 | 2021 | 2652 | 1.340 |
Why?
|
Retinal Detachment | 3 | 2020 | 428 | 1.300 |
Why?
|
Scleral Buckling | 2 | 2020 | 95 | 1.250 |
Why?
|
Myopia | 2 | 2021 | 251 | 1.250 |
Why?
|
Retinal Neovascularization | 3 | 2021 | 288 | 1.220 |
Why?
|
Fundus Oculi | 9 | 2021 | 548 | 1.130 |
Why?
|
Fovea Centralis | 3 | 2022 | 126 | 1.050 |
Why?
|
Retinal Perforations | 3 | 2016 | 138 | 1.020 |
Why?
|
Macular Edema | 2 | 2021 | 374 | 0.990 |
Why?
|
Ophthalmology | 3 | 2021 | 550 | 0.940 |
Why?
|
Vision Disorders | 4 | 2022 | 1088 | 0.940 |
Why?
|
Scotoma | 3 | 2020 | 130 | 0.910 |
Why?
|
Macula Lutea | 2 | 2021 | 169 | 0.850 |
Why?
|
Visual Field Tests | 5 | 2019 | 411 | 0.840 |
Why?
|
Retinal Hemorrhage | 3 | 2021 | 95 | 0.800 |
Why?
|
Central Serous Chorioretinopathy | 1 | 2022 | 27 | 0.790 |
Why?
|
Retinal Vein | 1 | 2021 | 47 | 0.740 |
Why?
|
Geographic Atrophy | 2 | 2019 | 83 | 0.730 |
Why?
|
Vitreous Hemorrhage | 1 | 2021 | 48 | 0.730 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2020 | 22 | 0.710 |
Why?
|
Visual Fields | 6 | 2019 | 1055 | 0.710 |
Why?
|
Optic Neuropathy, Ischemic | 2 | 2018 | 86 | 0.700 |
Why?
|
Microvessels | 5 | 2022 | 574 | 0.680 |
Why?
|
Presenilin-1 | 2 | 2021 | 659 | 0.680 |
Why?
|
Vitreoretinal Surgery | 1 | 2019 | 28 | 0.660 |
Why?
|
Eye Diseases, Hereditary | 1 | 2020 | 122 | 0.660 |
Why?
|
Artificial Intelligence | 4 | 2021 | 2568 | 0.660 |
Why?
|
Retinal Drusen | 3 | 2021 | 74 | 0.640 |
Why?
|
Vision, Ocular | 2 | 2022 | 454 | 0.640 |
Why?
|
Dark Adaptation | 5 | 2021 | 221 | 0.640 |
Why?
|
von Hippel-Lindau Disease | 1 | 2020 | 151 | 0.630 |
Why?
|
Exudates and Transudates | 1 | 2019 | 174 | 0.620 |
Why?
|
Diagnostic Techniques, Ophthalmological | 3 | 2019 | 251 | 0.610 |
Why?
|
Laser Coagulation | 1 | 2020 | 330 | 0.610 |
Why?
|
Eye Injuries | 3 | 2016 | 227 | 0.600 |
Why?
|
Polyhydroxyethyl Methacrylate | 1 | 2017 | 30 | 0.600 |
Why?
|
Giant Cell Arteritis | 2 | 2022 | 306 | 0.580 |
Why?
|
Chorioretinitis | 1 | 2017 | 43 | 0.580 |
Why?
|
Access to Information | 1 | 2020 | 316 | 0.570 |
Why?
|
Retinitis Pigmentosa | 1 | 2020 | 397 | 0.550 |
Why?
|
Optic Atrophy, Hereditary, Leber | 1 | 2016 | 50 | 0.530 |
Why?
|
Blindness | 1 | 2020 | 584 | 0.530 |
Why?
|
Emulsions | 2 | 2020 | 153 | 0.510 |
Why?
|
Contrast Sensitivity | 3 | 2022 | 244 | 0.500 |
Why?
|
Prosthesis Implantation | 3 | 2022 | 592 | 0.500 |
Why?
|
Angiography | 3 | 2022 | 1599 | 0.490 |
Why?
|
Silicone Oils | 1 | 2014 | 22 | 0.480 |
Why?
|
Optic Disk Drusen | 3 | 2021 | 38 | 0.470 |
Why?
|
Endotamponade | 1 | 2014 | 37 | 0.470 |
Why?
|
Prospective Studies | 19 | 2021 | 54304 | 0.460 |
Why?
|
Cross-Sectional Studies | 19 | 2022 | 26043 | 0.460 |
Why?
|
Regional Blood Flow | 1 | 2017 | 1486 | 0.450 |
Why?
|
Choroidal Neovascularization | 1 | 2017 | 363 | 0.440 |
Why?
|
Cataract Extraction | 1 | 2017 | 465 | 0.430 |
Why?
|
Diabetes Mellitus | 2 | 2021 | 5834 | 0.410 |
Why?
|
Prostheses and Implants | 2 | 2022 | 1272 | 0.390 |
Why?
|
Humans | 75 | 2022 | 760239 | 0.380 |
Why?
|
Surgery, Computer-Assisted | 1 | 2019 | 1006 | 0.380 |
Why?
|
Photography | 3 | 2021 | 531 | 0.320 |
Why?
|
Metabolomics | 4 | 2019 | 1654 | 0.310 |
Why?
|
Middle Aged | 33 | 2022 | 220307 | 0.300 |
Why?
|
Pilot Projects | 1 | 2021 | 8610 | 0.300 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39067 | 0.300 |
Why?
|
Female | 38 | 2022 | 391766 | 0.250 |
Why?
|
Male | 38 | 2022 | 359943 | 0.250 |
Why?
|
Postoperative Complications | 2 | 2017 | 15626 | 0.250 |
Why?
|
Biomedical Research | 1 | 2020 | 3421 | 0.240 |
Why?
|
Aged | 26 | 2021 | 168773 | 0.240 |
Why?
|
Corneal Diseases | 2 | 2022 | 541 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3081 | 0.210 |
Why?
|
Aged, 80 and over | 13 | 2020 | 58838 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3201 | 0.200 |
Why?
|
Retrospective Studies | 14 | 2022 | 80414 | 0.200 |
Why?
|
Alzheimer Disease | 2 | 2021 | 8577 | 0.200 |
Why?
|
Hypertension | 1 | 2022 | 8527 | 0.200 |
Why?
|
Adult | 18 | 2022 | 220718 | 0.200 |
Why?
|
Imaging, Three-Dimensional | 4 | 2019 | 4063 | 0.190 |
Why?
|
Intravitreal Injections | 3 | 2019 | 385 | 0.180 |
Why?
|
Glaucoma, Open-Angle | 2 | 2018 | 737 | 0.180 |
Why?
|
Muscle Spasticity | 1 | 2021 | 156 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8623 | 0.170 |
Why?
|
Electroretinography | 2 | 2020 | 521 | 0.170 |
Why?
|
Spinocerebellar Ataxias | 1 | 2021 | 104 | 0.170 |
Why?
|
Colombia | 1 | 2021 | 279 | 0.170 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2021 | 204 | 0.170 |
Why?
|
Vitreoretinopathy, Proliferative | 1 | 2020 | 76 | 0.170 |
Why?
|
Algorithms | 4 | 2021 | 13990 | 0.170 |
Why?
|
Glaucoma Drainage Implants | 1 | 2021 | 106 | 0.170 |
Why?
|
Papilledema | 1 | 2021 | 130 | 0.170 |
Why?
|
Intraocular Pressure | 3 | 2021 | 1290 | 0.170 |
Why?
|
Apolipoprotein E3 | 1 | 2019 | 107 | 0.170 |
Why?
|
Sclera | 1 | 2020 | 190 | 0.160 |
Why?
|
Glaucoma | 2 | 2022 | 1183 | 0.160 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2020 | 190 | 0.160 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2020 | 358 | 0.150 |
Why?
|
Intraoperative Period | 1 | 2019 | 511 | 0.150 |
Why?
|
Body Fluids | 1 | 2019 | 319 | 0.140 |
Why?
|
Nerve Fibers | 2 | 2017 | 708 | 0.140 |
Why?
|
Indocyanine Green | 1 | 2019 | 233 | 0.140 |
Why?
|
Mutation | 2 | 2021 | 30025 | 0.140 |
Why?
|
Retinal Pigment Epithelium | 2 | 2018 | 303 | 0.140 |
Why?
|
Capillaries | 2 | 2017 | 755 | 0.140 |
Why?
|
Vitreous Detachment | 1 | 2016 | 22 | 0.140 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2020 | 540 | 0.140 |
Why?
|
Fibrinolysin | 1 | 2016 | 131 | 0.140 |
Why?
|
Arterioles | 1 | 2017 | 250 | 0.140 |
Why?
|
Retinal Artery Occlusion | 1 | 2017 | 77 | 0.140 |
Why?
|
Coloring Agents | 1 | 2019 | 559 | 0.130 |
Why?
|
Angiogenesis Inhibitors | 2 | 2019 | 2047 | 0.130 |
Why?
|
Dilatation, Pathologic | 1 | 2017 | 527 | 0.130 |
Why?
|
Early Diagnosis | 1 | 2021 | 1183 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 736 | 0.130 |
Why?
|
Case-Control Studies | 4 | 2021 | 22079 | 0.120 |
Why?
|
Lyme Disease | 1 | 2021 | 630 | 0.120 |
Why?
|
Retinal Ganglion Cells | 2 | 2017 | 810 | 0.120 |
Why?
|
Oxidative Stress | 2 | 2016 | 3109 | 0.120 |
Why?
|
Vitreous Body | 1 | 2016 | 399 | 0.120 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2017 | 356 | 0.110 |
Why?
|
Age of Onset | 1 | 2021 | 3301 | 0.110 |
Why?
|
Granuloma | 1 | 2016 | 327 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12967 | 0.110 |
Why?
|
Basketball | 1 | 2013 | 46 | 0.110 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1967 | 0.100 |
Why?
|
Incidental Findings | 1 | 2017 | 697 | 0.100 |
Why?
|
Interleukin-8 | 1 | 2015 | 696 | 0.100 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20969 | 0.090 |
Why?
|
Daptomycin | 1 | 2011 | 71 | 0.090 |
Why?
|
Syndrome | 1 | 2017 | 3266 | 0.090 |
Why?
|
Staphylococcus epidermidis | 1 | 2011 | 124 | 0.090 |
Why?
|
Optic Nerve Diseases | 1 | 2014 | 342 | 0.090 |
Why?
|
Vancomycin Resistance | 1 | 2011 | 126 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 12123 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1084 | 0.090 |
Why?
|
Drug Substitution | 1 | 2013 | 288 | 0.090 |
Why?
|
Inflammasomes | 1 | 2015 | 523 | 0.090 |
Why?
|
Sarcoidosis | 1 | 2016 | 521 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2019 | 3486 | 0.090 |
Why?
|
DNA, Mitochondrial | 1 | 2015 | 869 | 0.090 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 664 | 0.080 |
Why?
|
Lipids | 2 | 2018 | 3341 | 0.080 |
Why?
|
Blast Injuries | 1 | 2013 | 322 | 0.080 |
Why?
|
Young Adult | 5 | 2022 | 59054 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8522 | 0.080 |
Why?
|
Endophthalmitis | 1 | 2011 | 260 | 0.080 |
Why?
|
Massachusetts | 1 | 2021 | 8826 | 0.080 |
Why?
|
Eye Infections, Bacterial | 1 | 2011 | 242 | 0.080 |
Why?
|
Boston | 1 | 2021 | 9324 | 0.070 |
Why?
|
Prognosis | 2 | 2020 | 29547 | 0.070 |
Why?
|
Fibrinolytic Agents | 1 | 2016 | 2081 | 0.070 |
Why?
|
Time Factors | 2 | 2021 | 39928 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2022 | 3206 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10534 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2021 | 64583 | 0.060 |
Why?
|
Software | 1 | 2019 | 4423 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2015 | 3207 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3439 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2365 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 1 | 2013 | 3734 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15252 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2016 | 5104 | 0.060 |
Why?
|
Cognition | 1 | 2021 | 6971 | 0.050 |
Why?
|
Schizophrenia | 1 | 2022 | 6925 | 0.050 |
Why?
|
Phenotype | 1 | 2021 | 16588 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11906 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 2011 | 1409 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4777 | 0.050 |
Why?
|
Rabbits | 2 | 2020 | 4780 | 0.040 |
Why?
|
MicroRNAs | 1 | 2016 | 3796 | 0.040 |
Why?
|
Portugal | 1 | 2020 | 91 | 0.040 |
Why?
|
Apolipoprotein E2 | 1 | 2019 | 135 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17859 | 0.040 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2020 | 224 | 0.040 |
Why?
|
Densitometry | 1 | 2018 | 151 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2019 | 3760 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 1633 | 0.040 |
Why?
|
Tonometry, Ocular | 1 | 2018 | 235 | 0.040 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.030 |
Why?
|
Ophthalmoscopy | 1 | 2017 | 171 | 0.030 |
Why?
|
Bruch Membrane | 1 | 2016 | 65 | 0.030 |
Why?
|
Sensory Thresholds | 1 | 2017 | 377 | 0.030 |
Why?
|
Tissue Adhesions | 1 | 2016 | 218 | 0.030 |
Why?
|
Vision, Low | 1 | 2017 | 163 | 0.030 |
Why?
|
Homozygote | 1 | 2019 | 1793 | 0.030 |
Why?
|
Aneurysm | 1 | 2018 | 336 | 0.030 |
Why?
|
Cornea | 1 | 2022 | 1331 | 0.030 |
Why?
|
Amyloid | 1 | 2019 | 840 | 0.030 |
Why?
|
Motor Skills | 1 | 2017 | 520 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 592 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2017 | 760 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7423 | 0.030 |
Why?
|
Explosions | 1 | 2013 | 108 | 0.030 |
Why?
|
Energy Intake | 1 | 2020 | 2133 | 0.020 |
Why?
|
Dietary Fats | 1 | 2020 | 1993 | 0.020 |
Why?
|
Pedigree | 1 | 2019 | 4586 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2016 | 1171 | 0.020 |
Why?
|
Chronic Disease | 2 | 2018 | 9304 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2189 | 0.020 |
Why?
|
Adolescent | 2 | 2015 | 88173 | 0.020 |
Why?
|
Antioxidants | 1 | 2016 | 1669 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18218 | 0.020 |
Why?
|
Child | 1 | 2015 | 80070 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6336 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2756 | 0.020 |
Why?
|
Life Style | 1 | 2018 | 3902 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5785 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2018 | 4024 | 0.020 |
Why?
|
Cataract | 1 | 2011 | 829 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14564 | 0.010 |
Why?
|
Cohort Studies | 2 | 2017 | 41340 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10491 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13230 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6297 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2015 | 4940 | 0.010 |
Why?
|
Diet | 1 | 2020 | 8046 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15602 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8466 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 12917 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15818 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10758 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20076 | 0.010 |
Why?
|
Internship and Residency | 1 | 2017 | 5864 | 0.010 |
Why?
|
Animals | 2 | 2020 | 168245 | 0.010 |
Why?
|
Brain | 1 | 2019 | 27049 | 0.010 |
Why?
|
United States | 1 | 2020 | 72181 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36351 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 73999 | 0.010 |
Why?
|